Cooper Companies | COO - Interest Expense On Debt



Cooper Companies reported $25.4M in Interest Expense on Debt for its fiscal quarter ending in July of 2025.


Interest Expense On Debt Change Date
Abbott USD 50M 1000K Jun/2025
Align Technology 0 0 Sep/2024
AtriCure USD 1.35M 79K Jun/2025
Avanos Medical USD 2M 100K Jun/2025
Bausch Health Companies USD 465M 135M Jun/2025
Baxter International USD 81M 19M Mar/2025
Bayer 495M 89M Jun/2025
Becton, Dickinson and Co. USD 152M 1000K Jun/2025
Boston Scientific USD 90M 8M Jun/2025
Cooper Companies USD 25.4M 1.2M Jul/2025
Dentsply International USD 24M 1000K Jun/2025
Dexcom USD 4.7M 0 Jun/2025
Edwards Lifesciences 15.5M 1000K Jun/2024
Globus Medical 4K 9K Jun/2025
Haemonetics USD 6.96M 1.36M Sep/2024
Hologic USD 28.9M 200K Jun/2025
Insulet USD 9.5M 8.3M Jun/2025
Integra LifeSciences USD 21.04M 2.23M Jun/2025
Intuitive Surgical 74.9M 18.8M Dec/2024
J&J USD 128M 9M Mar/2025
Medtronic USD 176M 2M Jul/2025
Merit Medical Systems USD 6.78M 207K Jun/2025
Novartis USD 289M 14M Jun/2025
ResMed USD -5757000 6.53M Jun/2025
STAAR Surgical USD 1000 0 Dec/2024
Steris USD 15.9M 1.21M Jun/2025
Stryker 42M 11M Sep/2024
Tandem Diabetes Care USD 1.9M 43K Jun/2025
Teleflex USD 21.71M 3.16M Jun/2025
Zimmer Biomet Holdings USD 79.3M 17.4M Jun/2025